Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 205501
Company: AMNEAL PHARMS
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
TOBRAMYCIN TOBRAMYCIN 300MG/5ML SOLUTION;INHALATION Prescription AN No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
07/13/2015 ORIG-1 Approval STANDARD Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/205501Orig1s000ltr.pdf

TOBRAMYCIN

SOLUTION;INHALATION; 300MG/5ML
TE Code = AN

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
KITABIS PAK TOBRAMYCIN 300MG/5ML SOLUTION;INHALATION Prescription No AN 205433 PULMOFLOW INC
TOBI TOBRAMYCIN 300MG/5ML SOLUTION;INHALATION Prescription Yes AN 050753 MYLAN SPECIALITY LP
TOBRAMYCIN TOBRAMYCIN 300MG/5ML SOLUTION;INHALATION Prescription No AN 201422 AKORN INC
TOBRAMYCIN TOBRAMYCIN 300MG/5ML SOLUTION;INHALATION Prescription No AN 205501 AMNEAL PHARMS
TOBRAMYCIN TOBRAMYCIN 300MG/5ML SOLUTION;INHALATION Prescription No AN 207080 DR REDDYS LABS SA
TOBRAMYCIN TOBRAMYCIN 300MG/5ML SOLUTION;INHALATION Prescription No AN 208964 LUPIN
TOBRAMYCIN TOBRAMYCIN 300MG/5ML SOLUTION;INHALATION Prescription No AN 209554 MYLAN
TOBRAMYCIN TOBRAMYCIN 300MG/5ML SOLUTION;INHALATION Prescription No AN 091589 TEVA PHARMS USA

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English